ClearBridge Investments’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
ACH
BG
NAMA
GS
ClearBridge Investments's CDNA Position: Q4 2022 in Review
ClearBridge Investments sold out of CareDx (CDNA) in Q4 2022, closing a stake of 1,664,147 shares — an estimated $28.3M sold.
ClearBridge Investments first reported a position in CDNA in Q3 2020 and held it in 9 quarters. The position peaked at $151M in Q2 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.
- ClearBridge Investments reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
- ClearBridge Investments sold 1,664,147 CareDx shares in Q4 2022, an estimated $28.3M.
- ClearBridge Investments first reported a position in CareDx in Q3 2020 and held it in 9 quarters.
- ClearBridge Investments's CareDx position peaked at $151M in Q2 2021.
- 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.
Based on ClearBridge Investments's 13F filing for Q4 2022, filed 10 Feb 2023.